Department of General Surgery, St. Giovanni Addolorata Hospital, Rome, Italy.
Department of Medical and Surgical Sciences and Translational Medicine, Sapienza University of Rome, St. Andrea University Hospital, Rome, Italy.
J Laparoendosc Adv Surg Tech A. 2024 Aug;34(8):671-676. doi: 10.1089/lap.2024.0190. Epub 2024 Aug 5.
Diastasis recti (DR) is a common condition, especially in women after pregnancy, often associated with concomitant hernia defects and defined as a rupture of the midline and a separation of the rectus muscle more than 2 cm. Symptoms related to this are low back pain, urinary incontinence and pelvic prolapse, as well as abdominal bulging and core instability. We analyzed clinical and functional outcomes after treatment of DR alone or associated with midline hernias in 219 patients who underwent a midline reconstruction using miSAR technique (minimally invasive stapled abdominal wall reconstruction). Between April 2019 and April 2022, 219 patients were treated with miSAR. All patients were requested to quantify preoperative and postoperative functional symptoms (urinary incontinence, low back pain, abdominal swelling, and respiratory distress). Twenty-seven men and 192 women underwent the miSAR technique. The mean body mass index was 23.9 kg/m. We performed the miSAR technique in patients affected by incisional midline hernia and umbilical hernia alone or associated with DR. Composite mesh was used in 91.8% of cases. The average operating time was 90 minutes. Seven percent of the patients had postoperative complications, including two retromuscular hematomas, two retromuscular seromas, and one postoperative bleeding event. Two patients were readmitted for bowel obstruction. After surgery, there was symptomatic improvement in urinary incontinence, low back pain, respiratory symptoms, and abdominal swelling; this improvement was confirmed at 6 months and at 1- and 2-year follow-up. At the 1-year follow-up, the overall recurrence rate was 2.83%. miSAR is a feasible and effective technique and shows promising results in the treatment of DR and ventral hernia. Possible enhancements include use of preoperative Botox to treat defects larger than 6 cm. Multicentric analysis is needed to validate the technique, and longer follow-up is required to assess the recurrence rate.
腹直肌分离(DR)是一种常见病症,尤其在女性妊娠后较为常见,常伴有并发疝缺陷,并定义为中线破裂和腹直肌分离超过 2 厘米。与该病症相关的症状包括下腰痛、尿失禁和骨盆脱垂,以及腹部膨出和核心不稳定。我们分析了 219 例接受 miSAR 技术(微创缝合腹壁重建)中线重建治疗的 DR 单独或合并中线疝患者的临床和功能结果。在 2019 年 4 月至 2022 年 4 月期间,219 例患者接受了 miSAR 治疗。所有患者均要求量化术前和术后的功能症状(尿失禁、下腰痛、腹部肿胀和呼吸困难)。27 例男性和 192 例女性接受了 miSAR 技术。平均体重指数为 23.9kg/m。我们在单纯切口中线疝和脐疝或合并 DR 的患者中进行了 miSAR 技术。复合网片在 91.8%的病例中使用。平均手术时间为 90 分钟。7%的患者发生术后并发症,包括 2 例肌后血肿、2 例肌后血清肿和 1 例术后出血事件。2 例患者因肠梗阻再次入院。手术后,尿失禁、下腰痛、呼吸症状和腹部肿胀症状均有改善;在 6 个月和 1 年及 2 年随访时得到了证实。在 1 年随访时,总复发率为 2.83%。miSAR 是一种可行且有效的技术,在治疗 DR 和腹疝方面显示出有前景的结果。可能的改进包括在术前使用肉毒毒素治疗大于 6cm 的缺陷。需要多中心分析来验证该技术,并且需要更长的随访时间来评估复发率。